Download PDF
Thromb Haemost 1982; 48(01): 038-040
DOI: 10.1055/s-0038-1657211
Original Article
Schattauer GmbH Stuttgart

“Lupus” Anticoagulant and Thrombosis – Possible Role of Inhibition of Prostacyclin Formation

L O Carreras
The Department of Medical Research, Center for Thrombosis and Vascular Research, University of Leuven, Belgium
,
J G Vermylen
The Department of Medical Research, Center for Thrombosis and Vascular Research, University of Leuven, Belgium
› Author Affiliations
Further Information

Publication History

Received 14 January 1982

Accepted 15 June 1982

Publication Date:
13 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

A “lupus” anticoagulant was discovered in 14 patients over a one year period. Only three of them had systemic lupus erythematosus. Bleeding manifestations were only present in one patient with concomitant severe thrombocytopenia. In contrast, eight patients had a history of thrombosis; five of them presented repeated thrombotic episodes. Obstetrical complications (recurrent abortion, fetal death, or intrauterine growth retardation) were observed in six patients. An inhibitory effect of plasma on the production of prostacyclin by vascular tissue was detected in eight patients, six of whom had thrombosis. We suggest that inhibition of prostacyclin formation could play a major role in the pathogenesis of thrombosis and obstetrical problems in some patients with this type of anticoagulant, even in the absence of systemic lupus erythematosus.

Keywords

“Lupus” anticoagulant - Thrombosis - Prostacyclin
 

  • References

  • 1 Veltkamp JJ, Kerkhoven P, Loeliger EA. Circulating anticoagulant in disseminated lupus erythematosus. Haemostasis 1973; 1974; 2: 253-259
    PubMedSearch in Google Scholar
  • 2 Thiagarajan P, Shapiro SS, De Marco L. Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant. J Clin Invest 1980; 66: 397-405
    CrossrefPubMedSearch in Google Scholar
  • 3 Feinstein DI, Rapaport SI. Acquired inhibitors of blood coagulation. Prog Hemost Thromb 1972; 1: 75-95
    PubMedSearch in Google Scholar
  • 4 Exner T, Rickard KA, Kronenberg H. A sensitive test demonstrating lupus anticoagulant and its behavioural patterns. Br J Haematol 1978; 40: 143-151
    CrossrefPubMedSearch in Google Scholar
  • 5 Boxer M, Ellman L, Carvalho A. The lupus anticoagulant. Arthritis Rheum 1976; 19: 1244-1248
    CrossrefPubMedSearch in Google Scholar
  • 6 Schleider MA, Nachman RL, Jaffe EA, Coleman M. A clinical study of the lupus anticoagulant. Blood 1976; 48: 499-509
    PubMedSearch in Google Scholar
  • 7 Conley CL, Hartmann RC. A haemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Clin Invest 1952; 31: 621-622
    PubMedSearch in Google Scholar
  • 8 Lechner K. Acquired inhibitors in nonhemophilic patients. Haemostasis 1974; 3: 65-93
    PubMedSearch in Google Scholar
  • 9 Mueh JR, Herbst KD, Rapaport SI. Thrombosis in patients with the lupus anticoagulant. Ann Intern Med 1980; 92: 156-159
    CrossrefPubMedSearch in Google Scholar
  • 10 Margolius Jr A, Jackson DP, Ratnoff OD. Circulating anticoagulants: a study of 40 cases and a review of the literature. Medicine (Baltimore) 1961; 40: 145-202
    CrossrefPubMedSearch in Google Scholar
  • 11 Bowie EW, Thompson JH, Cascuzzi PA, Owen GA. Thrombosis in SLE despite circulating anticoagulants. J Lab Clin Med 1963; 62: 416-430
    PubMedSearch in Google Scholar
  • 12 Carreras LO, Defreyn G, Machin SJ, Vermylen J, Deman R, Spitz B, van Assche A. Arterial thrombosis, intrauterine death and “lupus” anticoagulant. Detection of immunoglobulin interfering with prostacyclin formation. Lancet 1981; 1: 244-246
    PubMedSearch in Google Scholar
  • 13 Moneada S, Higgs EA, Vane JR. Human arterial and venous tissues generate prostacyclin (prostaglandin X), a potent inhibitor of platelet aggregation. Lancet 1977; 1: 18-20
    PubMedSearch in Google Scholar
  • 14 Carreras LO, Vermylen J, Spitz B, van Assche A. “Lupus” anticoagulant and inhibition of prostacyclin formation in patients with repeated abortion, intrauterine growth retardation and intrauterine death. Br J Obstet Gynaecol 1981; 88: 890-894
    CrossrefPubMedSearch in Google Scholar
  • 15 Clauvel JP, Sultan Y. Anticoagulant circulant et syndrome de Willebrand au cours du lupus érythémateux disséminé. Actual Hématol 1977; 11: 109-121
    PubMedSearch in Google Scholar
  • 16 Dubois EL, Tallman E, Wonka RA. Chlorpromazine-induced systemic lupus erythematosus. JAMA 1972; 221: 595-596
    CrossrefPubMedSearch in Google Scholar
  • 17 Williams H, Laurent R, Gibson T. The lupus coagulation inhibitor and venous thrombosis: a report of four cases. Clin Lab Haematol 1980; 1: 139-144
    PubMedSearch in Google Scholar
  • 18 Manoharan A, Gibson L, Rush B, Feery BJ. Recurrent venous thrombosis with a “lupus” coagulation inhibitor in the absence of systemic lupus. Aust N Z J Med 1977; 7: 638-641
    CrossrefPubMedSearch in Google Scholar
  • 19 Nilsson IM, Astedt B, Hedner U, Berezin D. Intrauterine death and circulating anticoagulant (“antithromboplastin”). Acta Med Scand 1975; 197: 153-159
    PubMedSearch in Google Scholar
  • 20 Soulier JP, Boffa MC. Avortements à répétition, thrombose et anticoagulant circulant anti-thromboplastine. Nouv Presse Méd 1980; 9: 859-864
    PubMedSearch in Google Scholar
  • 21 Firkin BG, Howard MA, Radford N. Possible relationship between lupus inhibitor and recurrent abortion in young women. Lancet 1980; 2: 366
    PubMedSearch in Google Scholar
  • 22 Marchesi D, Parbtani A, Frampton G, Livio M, Remuzzi G, Cameron JS. Thrombotic tendency in systemic lupus erythematosus. Lancet 1981; 1: 719
    PubMedSearch in Google Scholar
  • 23 McVerry BA, Machin SJ, Parry H, Goldstone AH. Reduced prostacyclin activity in systemic lupus erythematosus. Ann Rheum Dis 1980; 39: 524-525
    CrossrefPubMedSearch in Google Scholar
  • 24 Slater D. “Lupus” and prostacyclin formation. Lancet 1981; 1: 393
    PubMedSearch in Google Scholar
  • 25 Bamford DS, Jogee M, Williams KI. Prostacyclin formation by the pregnant human myometrium. Br J Obstet Gynaecol 1980; 87: 214-215
    PubMedSearch in Google Scholar
  • 26 Lewis PJ, Boylan P, Friedman LA, Hensby CN, Downing I. Prostacyclin in pregnancy. Br Med J 1980; 280: 1581-1582
    CrossrefPubMedSearch in Google Scholar
  • 27 Remuzzi G, Misiani R, Muratore D, Marchesi D, Livio M, Schieppati A, Mecca G, DeGaetano G, Donati MB. Prostacyclin and human foetal circulation. Prostaglandins 1979; 18: 341-348
    CrossrefPubMedSearch in Google Scholar
  • 28 Remuzzi G, Marchesi D, Zoja C, Muratore D, Mecca G, Misiani R, Rossi E, Barbato M, Capetta P, Donati MB, de Gaetano G. Reduced umbilical and placental vascular prostacyclin in severe pre-eclampsia. Prostaglandins 1980; 20: 105-110
    CrossrefPubMedSearch in Google Scholar
  • 29 Carreras LO, Defreyn G, van Houtte E, Vermylen J, van Assche A. Prostacyclin and pre-eclampsia. Lancet 1981; 1: 442
    PubMedSearch in Google Scholar
  • 30 Bussolino F, Benedetto C, Massobrio M, Camussi G. Maternal vascular prostacyclin activity in pre-eclampsia. Lancet 1980; 2: 702
    PubMedSearch in Google Scholar